For other salt forms please inquire. Agonist of P2Y1, P2Y12 and P2Y13 receptors. Detailed technical information available. References: Cusack et al., Br. J. Pharmacol., 77, 329 - 333 (1982); Boyer et al., J. Pharmacol. Exp. Ther., 267, 1140 - 1146 (1993).
Vial containing 500 µl of 10 mM aqueous solution of pH 7.6
| Cat. No. | M 020 |
| CAS number | [34983-48-7] |
| Purity | > 95% HPLC |
| Salt form | Sodium |
| Appearance | 10 mM aqueous solution of pH 7.6 |
| Storage temperature | -70°C / -94°F |
| Molecular formula | C₁₁H₁₇N₅O₁₀P₂S (free acid) |
| Molecular weight [g/mol] | 473.3 (free acid) |
| Absorption max [nm] | 277 |
| Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 14700 |
| UV pH value | 11 |
- 1. Herfindal L., Nygaard G., Kopperud R., Krakstad C., Doeskeland S. O.Selheim F., Biochem. Biophys. Res. Commun., 437, 603 - 608 (2013), "Off-Target Effect of the Epac Agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 Receptors in Blood Platelets"
- 2. Jacques-Silva M. C., Rodnight R., Lenz G., Liao Z., Kong Q., Tran M., Kang Y., Gonzalez F. A., Weisman G. A.Neary J. T., Br. J. Pharmacol., 141, 1106 - 1117 (2004), "P2X7 Receptors Stimulate AKT Phosphorylation in Astrocytes"
- 3. Claes P., Van Kolen K., Roymans D., Blero D., Vissenberg K., Erneux C., Verbelen J. P., Esmans E. L.Slegers H., Biochem. Pharmacol., 67, 1489 - 1498 (2004), "Reactive Blue 2 Inhibition of Cyclic AMP-dependent Differentiation of Rat C6 Glioma Cells by Purinergic Receptor-independent Inactivation of Phosphatidylinositol 3-kinase"
- 4. Marcet B., Chappe V., Delmas P.Verrier B., J. Pharmacol. Exp. Ther., 309, 533 - 539 (2004), "Pharmacological and Signaling Properties of Endogenous P2Y1 Receptors in Cystic Fibrosis Transmembrane Conductance Regulator-expressing Chinese Hamster Ovary Cells"
- 5. Malmsjö M., Hou M., Pendergast W., Erlinge D.Edvinsson L., Eur. J. Pharmacol., 458, 305 - 311 (2003), "The Stable Pyrimidines UDPbetaS and UTPgammaS Discriminate Between Contractile Cerebrovascular P2 Receptors"
- 6. Unterberger U., Moskvina E., Scholze T., Freissmuth M.Böhm S., Br. J. Pharmacol., 135, 673 - 684 (2002), "Inhibition of Adenylyl Cyclase by Neuronal P2Y Receptors"
- 7. Qi A.-D., Zambon A. C., Insel P. A.Nicholas R. A., Mol. Pharmacol., 60, 1375 - 1382 (2001), "An Arginine/Glutamine Difference at the Juxtaposition of Transmembrane Domain 6 and the Third Extracellular Loop Contributes to the Markledly Differnet Nucleotide Selectivities of Human and Canine P2Y(11) Receptors"
- 8. Vohringer C., Schäfer R.Reiser G., Biochem. Pharmacol., 59, 791 - 800 (2000), "A Chimeric Rat Brain P2Y(1) Receptor Tagged With Green-Fluorescent Protein: High-affinity Ligand Recognition of Adenosine Diphosphates and Triphosphates and Selectivity Identical to that of the Wild-type Receptor"
- 9. Jantzen H.-M., Gousset L., Bhaskar V., Vincent D., Tai A., Reynolds E. E.Conley P. B., Thromb. Haemost., 81, 111 - 117 (1999), "Evidence for Two Distinct G-Protein-coupled ADP Receptors Mediating Platelets Activation"
- 10. Geiger J., Hönig-Liedl P., Schanzenbächer P.Walter U., Eur. J. Pharmacol., 351, 235 - 246 (1998), "Ligand Specificity and Ticlopidine Effects Distinguish Three Human Platelet ADP Receptors"
- 11. Boyer J. L., Lazarowski E. R., Chen X. H.Harden T. K., J. Pharmacol. Exp. Ther., 267, 1140 - 1146 (1993), "Identification of a P2Y-Purinergic Receptor that Inhibits Adenylyl Cyclase"
- 12. Cusack N. J.Hourani S. M. O., Br. J. Pharmacol., 75, 397 - 400 (1982), "Specific but Noncompetitive Inhibition by 2-Alkylthio Analogues of Adenosine 5'-monophosphate and Adenosine 5'-triphosphate of Human Platelet Aggregation Induced by Adenosine 5'-diphosphate"
- 13. Cusack N. J.Hourani S. M. O., Br. J. Pharmacol., 77, 329 - 333 (1982), "Competitive Inhibition by Adenosine 5'-Triphosphate of the Actions on Human Platelets of 2-Chloroadenosine 5'-Diphosphate, 2-Azidoadenosine 5'-Diphosphate and 2-Methylthioadenosine 5'-Diphosphate"
